BB Biotech 2nd Line Ord Shs (BBZA) verðbréfaverð og fréttir – Google Finance

HeimBBZA • FRA

BB Biotech 2nd Line Ord Shs

40,35 €

29. nóv., 22:59:48 GMT+1 · EUR · FRA · Lagalegir fyrirvarar

HlutabréfSkráð hlutabréf í DEHöfuðstöðvar: CH

Við síðustu lokun

39,80 €

Dagbil

39,30 € - 40,45 €

Árabil

37,60 € - 52,60 €

Markaðsvirði

2,05 ma. CHF

Meðalmagn

3,31 þ.

V/H-hlutf.

-

A/V-hlutfall

-

Aðalkauphöll

SWX

Viðskiptafréttir

fyrir 12 klukkustundum

The Trump Trade rally has stocks at record highs. Where do we go from here?

fyrir 12 klukkustundum

Diversifying Beyond The Vanilla S&P 500: Two ETFs To Watch In 2025

Investor's Business Daily

fyrir 4 klukkustundum

Dow Jones Futures: Nvidia, Meta, Apple Eye Buy Points With Tesla FSD v13 Coming

New stock exchange aiming to offer 23-hour trading set to launch in 2025

3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever

S&P 500 Gains and Losses Today: Index Logs Record Close in Black Friday Session

Um

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Stofnsett

9. nóv. 1993

Höfuðstöðvar

Küsnacht Zürich
Sviss

Vefsvæði

Leit

Hreinsa leit

Loka leit

Google forrit

Aðalvalmynd